Androgen receptor expression in patients with triple negative breast cancer treated with neoadjuvant chemotherapy: A single institution experience.

被引：1
|
作者：
Glisch, Chad
Jawa, Zeeshan Ali
Badar, Talha
Visotcky, Alexis
Chaudhary, Lubna
Kamaraju, Sailaja
Burfeind, John D.
Charlson, John A.
Chitambar, Christopher R.
Lagunova, Valentina
Aguilera-Barrantes, Irene
Jorns, Julie
Cheng, Yee Chung
机构：
[1] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, Brookfield, WI USA
[3] Froedtert Med Coll Wisconsin, Milwaukee, WI USA
[4] Med Coll Wisconsin, Wauwatosa, WI USA
[5] Med Coll Wisconsin, Menomonee Falls, WI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e12662
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12662
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Androgen receptor expression in patients with triple negative breast cancer treated with neoadjuvant chemotherapy: a single institution study
    Sridhar, Nithya
    Glisch, Chad
    Jawa, Zeeshan
    Chaudhary, Lubna N.
    Kamaraju, Sailaja
    Burfeind, John
    Charlson, John
    Chitambar, Christopher R.
    Jorns, Julie M.
    Cheng, Yee Chung
    [J]. JOURNAL OF CANCER, 2022, 13 (08): : 2472 - 2476
  • [2] Androgen Receptor Expression in Triple Negative Breast Cancers: A Single Institution Experience
    Muthukumarana, Palawinnage Vidarshi U.
    Segura, Sheila E.
    Profeta, Theresa L.
    Vidhun, Ramapriya
    [J]. LABORATORY INVESTIGATION, 2016, 96 : 60A - 61A
  • [3] Androgen Receptor Expression in Triple Negative Breast Cancers: A Single Institution Experience
    Muthukumarana, Palawinnage Vidarshi U.
    Segura, Sheila E.
    Profeta, Theresa L.
    Vidhun, Ramapriya
    [J]. MODERN PATHOLOGY, 2016, 29 : 60A - 61A
  • [4] Androgen receptor expression and outcome of neoadjuvant chemotherapy in triple-negative breast cancer
    Di Leone, A.
    Fragomeni, S. M.
    Scardina, L.
    Ionta, L.
    Mule, A.
    Magno, S.
    Terribile, D.
    Masetti, R.
    Franceschini, G.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (04) : 1910 - 1915
  • [5] Neoadjuvant chemotherapy in cervical cancer patients: a single institution experience.
    Destefanis, Matilde
    Filippeschi, Marco
    Zipoli, Giuditta
    Dentico, Patrizia
    Gabbanini, Massimo
    Gemelli, Maria Teresa
    Giannessi, Pier Giorgio
    Muto, Andrea
    Rossi, Susanna
    Turrisi, Gina
    Milandri, Carlo
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [6] Sentinel lymph node biopsy and neoadjuvant chemotherapy in breast cancer patients: a single institution experience.
    Rebollo-Aguirre, A. C.
    Testart, N.
    Sanchez-Sanchez, R.
    Aroui, T.
    Trivino-Ibanez, E.
    Garcia-Garcia, J.
    Menjon-Beltran, S.
    Llamas-Elvira, J. M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S707 - S707
  • [7] PARP1, BRCA1 and androgen receptor expression in triple-negative breast cancer patients treated with neoadjuvant chemotherapy
    Rashed, Hayam E.
    Monged, Randa E.
    Nawar, Nashwa
    Alattar, Ahmed Z.
    Alnagar, Ahmed A.
    Abdelhamid, Mohamed I.
    Abdelaziz, Osama
    Said, Nelly M.
    [J]. REVISTA DE SENOLOGIA Y PATOLOGIA MAMARIA, 2022, 35 (04): : 228 - 235
  • [8] Outcomes of neoadjuvant (NA) and adjuvant (A) chemotherapy in geriatric patients with stage I-III triple-negative breast cancer (TNBC): A single institution experience.
    Sam, Christine
    Sehovic, Marina
    Extermann, Martine
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [9] 5 year Overall survival of triple negative breast cancer: A single institution experience.
    Skandan, Savitri Padmanabhan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [10] A SINGLE INSTITUTION EXPERIENCE WITH TRIPLE NEGATIVE BREAST CANCER
    Rezazadeh, A.
    Kloecker, G.
    Kruse, B. B.
    Jain, D.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 : 49 - 49
12345